Dr. Lal PathLabs has received an approval to acquire to 70 per cent stake in Dr. Lal Path Labs Bangladesh (DLPLB) from its existing shareholders, with the objective of strengthening its presence in Bangladesh. Prior to the company’s investment, DLPLB shall be acquiring the running diagnostics business of a sole-proprietorship firm in Dhaka, Bangladesh.
The Board of Directors of the Company at their meeting held on August 07, 2017, has given the approval for the same.
Dr. Lal PathLabs is a provider of diagnostic and related healthcare tests and services in India. Through its integrated, nationwide network, the company offers patients and healthcare providers a broad range of diagnostic and related healthcare tests and services for use in core testing, patient diagnosis and the prevention, monitoring and treatment of disease and other health conditions.
Company Name | CMP |
---|---|
Apollo Hospital Ent. | 7322.90 |
Max Healthcare Inst | 1157.00 |
Narayana Hrudayalay | 1306.00 |
Aster DM Healthcare | 505.30 |
Global Health | 1102.65 |
View more.. |